IMPULSE Dynamics, a global medical device company dedicated to improving people’s lives with heart failure, announced on Nov 2, the first implantation of a patient in China with its innovative Optimizer system delivering CCM therapy.
The successful implant technique was carried out by cardiologist Dr Hua Wei of the renowned Fuwai Hospital of the Chinese Academy of Medical Sciences.
Dr Wei shared: “We are currently relying on medication only for the treatment of heart failure. If medication doesn’t work, then we don’t have a better solution.
We now have a new option — CCM therapy — for these patients with narrow QRS heart failure. For most patients with heart failure, I think the implant performed today has a significant meaning for the future.”
The Optimiser, harnessing advanced engineering, delivers CCM therapy — the company’s proprietary technology — to the heart.
Impulse Dynamics has pioneered CCM therapy to significantly improve heart contraction, allowing more oxygen-rich blood to be pushed throughout the body.
The Optimizer delivers precisely timed electrical pulses to the heart during the absolute refractory period of the beating cycle, immediately after the heart contracts.
This breakthrough device improves the quality of life for heart failure patients no longer benefit from a medication meant to manage symptoms and slow the progression of their condition.
“Following years of collaboration between accomplished Chinese clinicians and our local team to obtain market authorisation, we are happy to be offering the breakthrough technology of CCM therapy to Chinese patients and their families to restore their quality of life and help them regain hope,” said Simos Kedikoglou, CEO of Impulse Dynamics. — The Health
